HealthNotableSingle-sourceDeveloping
5.2
Pharmaceutical firms advance late-stage therapies for Lp(a) cardiovascular risk
STAT NewsLO·US·about 23 hours ago
The White House is preparing to announce new negotiated drug pricing agreements with biotechnology companies. The specific terms, participating firms, and impact on pharmaceutical revenue remain unconfirmed pending the official release.
Locations
Entities